***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we have closed five positions; three for some nice gains and two for losses, one of which was highly unexpected and very ugly.

GOAMERICA (9/5/06). Closed position 11/9/06 at $4.60 for a 53% GAIN.

Q COMM (3/5/06). Closed position 11/9/06 at 29¢ for a 88% LOSS.

MICROVISION (7/20/06). Closed position 11/2/06 at $2.95 for a 68% GAIN.

ICAD (5/20/06). Closed position 11/2/06 at $2.68 for a 60% GAIN.

MONOGRAM BIOSCIENCES (7/20/01). Closed position 11/2/06 at $1.65 for a 52% LOSS.

(more…)

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we closed four positions; three for some okay gains and one for a loss.

GENVEC (10/5/06). Closed position 10/19/06 at $1.80 for a 62% GAIN.

ORCHARD CELLMARK (9/20/06). Closed position 10/19/06 at $3.38 for a 50% GAIN.

INFINITY PHARMA (10/5/05). Closed position 10/18/06 at $15.50 for a 20% GAIN.

VERTICALNET (4/5/05). Closed position 10/18/06 at 75¢ for a 88% LOSS. (price reflects reverse split)

(more…)

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Although we have not closed any new positions since the last Newsletter, much of our Current Portfolio is looking better than it did a few months ago when the markets were in the pits. The Dow continues to make new highs but the NASDAQ, while seeing modest gains, seems to be a reluctant party-goer. However, small stocks have finally started to pop during the last week, as witnessed by the Russell 2000, which has had a nice 5% to 7% surge since the second week of the month.

Here are the headlines since the last Newsletter about companies in the Current Portfolio. Dates in parentheses are when we first recommended them.

(more…)

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we have closed three more positions; two for some nice gains and one for a loss.

INVESTORS CAPITAL (4/20/06). Closed position 9/18/06 at $5.24 for a 65% GAIN.

ADVANCIS PHARMA (12/20/04). Closed position 9/18/06 at $5.69 for a 52% GAIN.

NEXMED (4/5/04). Closed position 9/18/06 at 76 for a 72% LOSS.

Investors Capital had a nice upward spike, probably due to the fact that many brokerage firms should be reporting good results for the current quarter. Over the last few years, Advancis was a roller coaster ride, and it appears that good FDA news on a drug trial spurred AVNC’s stock.NexMed was, of course, a major disappointment, and with a worsening balance sheet, it is time to take the loss.

(more…)

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we closed one position, for a pretty nice gain.

AMERICAN TECHNOLOGY (8/5/06). Closed position 9/5/06 at $3.45 for a 60% GAIN.

We must remind you that American Technology is the exception and not the norm; it was in the Current Portfolio for less than two months. Since picking it, ATCO climbed pretty steadily behind some pretty good news.

This isn’t supposed to be. Traditionally, September has been the worst month of the year for the markets. What is different this time? The simple explanation being served up is plunging oil prices, and that makes sense to us. However, the month isn’t quite over, just yet, and, soon, inventors will find something else to fret about, such as another spike upward in crude prices, the upcoming mid-term elections, etc. But, for now, enjoy the ride.

Here are the headlines since the last Newsletter about companies in the Current Portfolio. Dates in parentheses are when we first recommended them.

(more…)

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

During the last couple of weeks, the markets added to their August gains, albeit, with some trepidation. There seems to be a lot of investor jitters over what the Fed will do at its next meeting, slated for later this month. We suspect another rate hike, although we believe the central bank has already gone overboard, which has usually been its history. What the markets do after that may hinge upon the statement that accompanies the rate hike. And, all of this could very well help determine the outcome of the midterm elections, which should be the market’s next bugaboo.

As you can tell, we did not close any new positions over the last half month, but our Current Portfolio, while still battered from early summer’s plunge, held pretty steady, overall, and improved in many spots.

(more…)

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Finally! Our multi-month drought has ended as we close three positions since the last Newsletter, one for a nice gain, one for an okay gain (that was forced), and one for a loss that could have been much uglier than it was.

CLICKSOFTWARE (4/5/06). Closed position 8/16/06 at $2.42 for a 53% GAIN.

MICRO LINEAR (6/5/06). Closed position 8/16/06 at $3.30 for a 20% GAIN.

LOUDEYE (4/5/05). Closed position 8/16/06 at $4.36 for a 69% LOSS.

(more…)

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Back in May, we said that the summer market direction would be decided by what the Fed did in June, and that’s what happened. And, it has been ugly. Our Current Portfolio has taken its worst drubbing since the corporate scandals back in 2002. It is pretty safe to say that what the Fed does next week will dictate the market’s action well into the Fall; of course, so will oil prices. During the last week of July, we had a nice upswing because the gurus think the Fed will do nothing. It’s nail-biting time.

Here are the headlines since the last Newsletter about companies in our Current Portfolio. Dates in parentheses are when we first recommended them.

(more…)

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Yes, things just keep getting uglier and uglier, and, if we see a slew of disappointing earnings from the big caps over the next few weeks, maybe the market will have the capitulation that some gurus think it needs.  The main cause for the doldrums is the ever-rising price of oil, which, has now seeped into all aspects and areas of the economy.  At some point, the carnage will end, and, as we said last issue, it should be sooner rather than later.  And yes, once again, our Current Portfolio has also taken a beating.

Here are the headlines since the last Newsletter about companies in the Current Portfolio.  Dates in parentheses are when we first recommended them.

(more…)

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Our favorite saying of late has been “hit the replay button”. The markets and our Current Portfolio are still in their worst slump in over three years and for all of the reasons we cited in our last several Newsletters. But, remember one thing. This, too, shall pass. When? We’re optimistic that it will be sooner rather than later, however, in the meantime, expect more gut-wrenching days laced with a few euphoric ones.

(more…)